/CCORF
CCORF Stock - Canaccord Genuity Group Inc.
Financial Services|Financial - Capital MarketsOTC
$8.40+0.00%
+$0.00 (+0.00%) • Dec 19
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.79
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.54
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $9.24
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CCORF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$8.32 – $8.48
TARGET (TP)$9.66
STOP LOSS$7.73
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.66
52W High$8.80
52W Low$5.38
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.77B | $1.48B | $1.51B | $2.05B | $2.01B |
| Gross Profit | $634.09M | $535.65M | $477.44M | $694.99M | $657.64M |
| Gross Margin | 35.8% | 36.2% | 31.6% | 34.0% | 32.8% |
| Operating Income | $206.09M | $176.06M | $127.49M | $425.71M | $409.46M |
| Net Income | $-17,499,000 | $-13,163,000 | $-90,104,000 | $246.31M | $263.79M |
| Net Margin | -1.0% | -0.9% | -6.0% | 12.0% | 13.1% |
| EPS | $-0.30 | $-0.27 | $-1.03 | $2.50 | $2.63 |
Company Overview
Canaccord Genuity Group Inc., a full-service financial services company, provides investment products, and investment banking and brokerage services to institutional, corporate, and private clients. It operates in two segments, Canaccord Genuity Capital Markets and Canaccord Genuity Wealth Management. The Canaccord Genuity Capital Markets segment offers investment banking, advisory, research, merger and acquisition, sales, and trading services. The Canaccord Genuity Wealth Management segment provides wealth management solutions, and brokerage and financial planning services to individual investors, private clients, charities, and intermediaries. The company operates in North America, the United Kingdom, Europe, Asia, Australia, and the Middle East. Canaccord Genuity Group Inc. was founded in 1950 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CCORFBeat Rate
37%
Last 19 quarters
Avg Surprise
-109.6%
EPS vs Estimate
Beats / Misses
7/12
Last 12 quarters
Latest EPS
$-1.03
Q4 2025
EPS Surprise History
Q1 24
+31.4%
$0.12vs$0.09
Q2 24
-121.6%
$-0.03vs$0.14
Q3 24
-74.7%
$0.04vs$0.15
Q4 24
-109.0%
$-0.01vs$0.16
Q1 25
-197.1%
$-0.16vs$0.17
Q2 25
-89.7%
$0.01vs$0.12
Q3 25
-238.3%
$-0.21vs$0.15
Q4 25
-803.0%
$-1.03vs$0.15
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 3, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | $0.15 | $-1.03 | -803.0% | ✗ MISS |
Q3 2025 | Aug 6, 2025 | $0.15 | $-0.21 | -238.3% | ✗ MISS |
Q2 2025 | Jun 4, 2025 | $0.12 | $0.01 | -89.7% | ✗ MISS |
Q1 2025 | Feb 5, 2025 | $0.17 | $-0.16 | -197.1% | ✗ MISS |
Q4 2024 | Nov 8, 2024 | $0.16 | $-0.01 | -109.0% | ✗ MISS |
Q3 2024 | Aug 8, 2024 | $0.15 | $0.04 | -74.7% | ✗ MISS |
Q2 2024 | Jun 5, 2024 | $0.14 | $-0.03 | -121.6% | ✗ MISS |
Q1 2024 | Mar 14, 2024 | $0.09 | $0.12 | +31.4% | ✓ BEAT |
Q4 2023 | Nov 15, 2023 | $0.06 | $-0.13 | -316.3% | ✗ MISS |
Q3 2023 | Aug 4, 2023 | $0.12 | $-0.09 | -174.7% | ✗ MISS |
Q2 2023 | Jun 16, 2023 | $0.18 | $-0.04 | -120.2% | ✗ MISS |
Q1 2023 | Feb 8, 2023 | $0.26 | $0.16 | -38.5% | ✗ MISS |
Q4 2022 | Nov 2, 2022 | $0.17 | $0.25 | +47.1% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $0.31 | $0.11 | -64.5% | ✗ MISS |
Q2 2022 | Jun 2, 2022 | $0.45 | $0.52 | +15.6% | ✓ BEAT |
Q1 2022 | Feb 8, 2022 | $0.63 | $0.69 | +9.5% | ✓ BEAT |
Q4 2021 | Nov 7, 2021 | $0.40 | $0.58 | +45.0% | ✓ BEAT |
Q3 2021 | Aug 2, 2021 | $0.59 | $0.73 | +23.7% | ✓ BEAT |
Q2 2021 | May 31, 2021 | $0.62 | $1.20 | +93.5% | ✓ BEAT |
Latest News
Canaccord Genuity Maintains Hold on FuelCell Energy, Maintains $12 Price Target
➖ NeutralBenzinga•Dec 19, 2025, 03:14 PM•Also:
Canaccord Genuity Maintains Hold on BlackBerry, Maintains $4.6 Price Target
➖ NeutralBenzinga•Dec 19, 2025, 03:09 PM•Also:
Canaccord Genuity Maintains Buy on Atara Biotherapeutics, Raises Price Target to $25
📈 PositiveBenzinga•Dec 19, 2025, 03:07 PM•Also:
Canaccord Genuity Maintains Buy on Worthington Enterprises, Lowers Price Target to $69
➖ NeutralBenzinga•Dec 18, 2025, 06:29 PM•Also:
Canaccord Genuity Initiates Coverage On Veru with Buy Rating, Announces Price Target of $25
📈 PositiveBenzinga•Dec 18, 2025, 12:50 PM
Canaccord Genuity Maintains Buy on Hut 8, Raises Price Target to $62
📈 PositiveBenzinga•Dec 18, 2025, 12:28 PM•Also:
Canaccord Genuity Maintains Buy on SI-BONE, Raises Price Target to $27
📈 PositiveBenzinga•Dec 17, 2025, 08:24 PM•Also:
Canaccord Genuity Maintains Buy on KORU Medical Systems, Raises Price Target to $6
📈 PositiveBenzinga•Dec 17, 2025, 08:20 PM
Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $50
➖ NeutralBenzinga•Dec 17, 2025, 08:14 PM•Also:
Canaccord Genuity Maintains Buy on Tandem Diabetes Care, Raises Price Target to $35
📈 PositiveBenzinga•Dec 17, 2025, 08:12 PM•Also:
Canaccord Genuity Maintains Buy on TransMedics Group, Raises Price Target to $148
📈 PositiveBenzinga•Dec 17, 2025, 08:10 PM•Also:
Canaccord Genuity Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12
📈 PositiveBenzinga•Dec 17, 2025, 08:08 PM•Also:
Canaccord Genuity Maintains Buy on Insulet, Raises Price Target to $450
📈 PositiveBenzinga•Dec 17, 2025, 08:06 PM•Also:
Canaccord Genuity Maintains Buy on Penumbra, Raises Price Target to $359
📈 PositiveBenzinga•Dec 17, 2025, 08:03 PM•Also:
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $99
📈 PositiveBenzinga•Dec 17, 2025, 08:00 PM•Also:
Canaccord Genuity Maintains Buy on CeriBell, Raises Price Target to $30
📈 PositiveBenzinga•Dec 17, 2025, 07:55 PM•Also:
Canaccord Genuity Maintains Buy on Boston Scientific, Lowers Price Target to $131
➖ NeutralBenzinga•Dec 17, 2025, 07:54 PM•Also:
Canaccord Genuity Maintains Hold on InMode, Lowers Price Target to $15
📉 NegativeBenzinga•Dec 17, 2025, 07:53 PM•Also:
Canaccord Genuity Maintains Buy on Globus Medical, Raises Price Target to $105
📈 PositiveBenzinga•Dec 17, 2025, 07:51 PM•Also:
Canaccord Genuity Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $85
📈 PositiveBenzinga•Dec 17, 2025, 07:45 PM•Also:
Frequently Asked Questions about CCORF
What is CCORF's current stock price?
Canaccord Genuity Group Inc. (CCORF) is currently trading at $8.40 per share. The stock has moved +0.00% today.
What is the analyst price target for CCORF?
No analyst price targets are currently available for this stock.
What sector is Canaccord Genuity Group Inc. in?
Canaccord Genuity Group Inc. operates in the Financial Services sector, specifically within the Financial - Capital Markets industry. The company is traded on the OTC exchange.
What is CCORF's market cap?
Canaccord Genuity Group Inc. has a market capitalization of $0.84 billion, making it a small-cap company.
Does CCORF pay dividends?
No, Canaccord Genuity Group Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorCBGPF
Close Brothers Group plc
$5.52
Mkt Cap: $0.8B
CBGPY
Close Brothers Group plc
$11.02
Mkt Cap: $0.8B
DGTLF
OCI International Holdings Limited
$0.04
Mkt Cap: $0.1B
EFGZF
EFG Holding S.A.E. Sponsored GDR RegS
$0.51
Mkt Cap: $0.7B
GEVI
General Enterprise Ventures, Inc.
$8.50
Mkt Cap: $0.1B
HACBY
The Hachijuni Bank, Ltd.
$22.06
Mkt Cap: $1.0B
PHIG
PHI Group, Inc.
$32.00
Mkt Cap: $0.8B
SGCFF
Sagicor Financial Company Ltd.
$6.71
Mkt Cap: $0.9B
SHGKY
Sun Hung Kai & Co. Limited
$2.01
Mkt Cap: $0.8B
WTBFB
W.T.B. Financial Corporation
$350.00
Mkt Cap: $0.9B
Explore stocks similar to CCORF for comparison